The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
The London office of Morrison & Foerster (MoFo) has taken advantage of the M&A boom in life sciences, signing off two deals in one week. The firm acted for the buyer in one deal and the seller in the other.
MoFo corporate partner James Gubbins advised Oxford BioMedica on its purchase of Oxxon Therapeutics, while corporate partner Paul Claydon represented long-term client Paradigm Therapeutics on its sale to Japanese pharma giant Takeda Pharmaceutical Company.
WilmerHale acted for Oxxon and Allen & Overy advised Takeda. MoFo has been active in the life sciences sector over the past few months, advising Arrow on its sale to AstraZeneca and Tanox on its $919m (£465m) sale to Genentech.